nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—ALB—Auranofin—psoriatic arthritis	0.252	0.303	CbGbCtD
Rosiglitazone—CYP2A6—Prednisolone—psoriatic arthritis	0.133	0.16	CbGbCtD
Rosiglitazone—ALB—Prednisone—psoriatic arthritis	0.0803	0.0964	CbGbCtD
Rosiglitazone—CYP2A6—Dexamethasone—psoriatic arthritis	0.0786	0.0943	CbGbCtD
Rosiglitazone—SLCO1B1—Methotrexate—psoriatic arthritis	0.0736	0.0883	CbGbCtD
Rosiglitazone—CYP2C19—Prednisone—psoriatic arthritis	0.0521	0.0625	CbGbCtD
Rosiglitazone—ALB—Methotrexate—psoriatic arthritis	0.0403	0.0483	CbGbCtD
Rosiglitazone—CYP2C8—Dexamethasone—psoriatic arthritis	0.0387	0.0465	CbGbCtD
Rosiglitazone—CYP2C19—Dexamethasone—psoriatic arthritis	0.0325	0.039	CbGbCtD
Rosiglitazone—CYP2C9—Dexamethasone—psoriatic arthritis	0.027	0.0324	CbGbCtD
Rosiglitazone—CYP2D6—Dexamethasone—psoriatic arthritis	0.0247	0.0297	CbGbCtD
Rosiglitazone—Hepatic enzyme increased—Auranofin—psoriatic arthritis	0.00486	0.0291	CcSEcCtD
Rosiglitazone—Haematocrit decreased—Methotrexate—psoriatic arthritis	0.00239	0.0143	CcSEcCtD
Rosiglitazone—Fracture—Methylprednisolone—psoriatic arthritis	0.00231	0.0139	CcSEcCtD
Rosiglitazone—Multiple fractures—Methylprednisolone—psoriatic arthritis	0.00231	0.0139	CcSEcCtD
Rosiglitazone—Eye disorder—Auranofin—psoriatic arthritis	0.00216	0.0129	CcSEcCtD
Rosiglitazone—Multiple fractures—Betamethasone—psoriatic arthritis	0.0021	0.0126	CcSEcCtD
Rosiglitazone—Multiple fractures—Dexamethasone—psoriatic arthritis	0.0021	0.0126	CcSEcCtD
Rosiglitazone—Fracture—Dexamethasone—psoriatic arthritis	0.0021	0.0126	CcSEcCtD
Rosiglitazone—Fracture—Betamethasone—psoriatic arthritis	0.0021	0.0126	CcSEcCtD
Rosiglitazone—Visual acuity reduced—Dexamethasone—psoriatic arthritis	0.00206	0.0123	CcSEcCtD
Rosiglitazone—Visual acuity reduced—Betamethasone—psoriatic arthritis	0.00206	0.0123	CcSEcCtD
Rosiglitazone—Anaemia—Auranofin—psoriatic arthritis	0.00186	0.0111	CcSEcCtD
Rosiglitazone—Hypertriglyceridaemia—Prednisone—psoriatic arthritis	0.00185	0.0111	CcSEcCtD
Rosiglitazone—Angioedema—Auranofin—psoriatic arthritis	0.00184	0.011	CcSEcCtD
Rosiglitazone—Fracture—Prednisone—psoriatic arthritis	0.00183	0.011	CcSEcCtD
Rosiglitazone—Multiple fractures—Prednisone—psoriatic arthritis	0.00183	0.011	CcSEcCtD
Rosiglitazone—Leukopenia—Auranofin—psoriatic arthritis	0.0018	0.0108	CcSEcCtD
Rosiglitazone—Blood triglycerides increased—Prednisone—psoriatic arthritis	0.00162	0.00974	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00161	0.00963	CcSEcCtD
Rosiglitazone—Fracture—Methotrexate—psoriatic arthritis	0.00153	0.00918	CcSEcCtD
Rosiglitazone—Multiple fractures—Methotrexate—psoriatic arthritis	0.00153	0.00918	CcSEcCtD
Rosiglitazone—Constipation—Auranofin—psoriatic arthritis	0.0014	0.00841	CcSEcCtD
Rosiglitazone—Fluid retention—Prednisolone—psoriatic arthritis	0.00139	0.00834	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Prednisolone—psoriatic arthritis	0.0013	0.00782	CcSEcCtD
Rosiglitazone—Urticaria—Auranofin—psoriatic arthritis	0.0013	0.00781	CcSEcCtD
Rosiglitazone—Fluid retention—Triamcinolone—psoriatic arthritis	0.00128	0.00767	CcSEcCtD
Rosiglitazone—Fluid retention—Methylprednisolone—psoriatic arthritis	0.00128	0.00765	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Prednisolone—psoriatic arthritis	0.00122	0.00733	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Triamcinolone—psoriatic arthritis	0.0012	0.00719	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Methylprednisolone—psoriatic arthritis	0.0012	0.00718	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Prednisolone—psoriatic arthritis	0.00117	0.00703	CcSEcCtD
Rosiglitazone—Pleural effusion—Methotrexate—psoriatic arthritis	0.00116	0.00697	CcSEcCtD
Rosiglitazone—Fluid retention—Betamethasone—psoriatic arthritis	0.00116	0.00696	CcSEcCtD
Rosiglitazone—Fluid retention—Dexamethasone—psoriatic arthritis	0.00116	0.00696	CcSEcCtD
Rosiglitazone—Pruritus—Auranofin—psoriatic arthritis	0.00116	0.00696	CcSEcCtD
Rosiglitazone—Increased appetite—Prednisolone—psoriatic arthritis	0.00113	0.00679	CcSEcCtD
Rosiglitazone—Hypercholesterolaemia—Prednisone—psoriatic arthritis	0.00113	0.00675	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Triamcinolone—psoriatic arthritis	0.00112	0.00674	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Methylprednisolone—psoriatic arthritis	0.00112	0.00673	CcSEcCtD
Rosiglitazone—Diarrhoea—Auranofin—psoriatic arthritis	0.00112	0.00673	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Betamethasone—psoriatic arthritis	0.00109	0.00653	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Dexamethasone—psoriatic arthritis	0.00109	0.00653	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Triamcinolone—psoriatic arthritis	0.00108	0.00647	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Methylprednisolone—psoriatic arthritis	0.00108	0.00645	CcSEcCtD
Rosiglitazone—Increased appetite—Triamcinolone—psoriatic arthritis	0.00104	0.00624	CcSEcCtD
Rosiglitazone—Increased appetite—Methylprednisolone—psoriatic arthritis	0.00104	0.00623	CcSEcCtD
Rosiglitazone—Rash—Auranofin—psoriatic arthritis	0.00103	0.0062	CcSEcCtD
Rosiglitazone—Dermatitis—Auranofin—psoriatic arthritis	0.00103	0.00619	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Betamethasone—psoriatic arthritis	0.00102	0.00612	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Dexamethasone—psoriatic arthritis	0.00102	0.00612	CcSEcCtD
Rosiglitazone—Fluid retention—Prednisone—psoriatic arthritis	0.00101	0.00606	CcSEcCtD
Rosiglitazone—Cardiac failure—Methylprednisolone—psoriatic arthritis	0.001	0.006	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Betamethasone—psoriatic arthritis	0.000978	0.00587	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Dexamethasone—psoriatic arthritis	0.000978	0.00587	CcSEcCtD
Rosiglitazone—Hyperbilirubinaemia—Methotrexate—psoriatic arthritis	0.000978	0.00587	CcSEcCtD
Rosiglitazone—Nausea—Auranofin—psoriatic arthritis	0.000974	0.00584	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Prednisone—psoriatic arthritis	0.000948	0.00568	CcSEcCtD
Rosiglitazone—Increased appetite—Dexamethasone—psoriatic arthritis	0.000944	0.00566	CcSEcCtD
Rosiglitazone—Increased appetite—Betamethasone—psoriatic arthritis	0.000944	0.00566	CcSEcCtD
Rosiglitazone—Hepatic enzyme increased—Methotrexate—psoriatic arthritis	0.000941	0.00564	CcSEcCtD
Rosiglitazone—Cardiac failure—Dexamethasone—psoriatic arthritis	0.000909	0.00545	CcSEcCtD
Rosiglitazone—Cardiac failure—Betamethasone—psoriatic arthritis	0.000909	0.00545	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Prednisone—psoriatic arthritis	0.000888	0.00533	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Prednisone—psoriatic arthritis	0.000852	0.00511	CcSEcCtD
Rosiglitazone—Weight increased—Prednisolone—psoriatic arthritis	0.000836	0.00502	CcSEcCtD
Rosiglitazone—Increased appetite—Prednisone—psoriatic arthritis	0.000823	0.00493	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.000808	0.00485	CcSEcCtD
Rosiglitazone—Myocardial infarction—Prednisolone—psoriatic arthritis	0.000803	0.00482	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Methotrexate—psoriatic arthritis	0.000792	0.00475	CcSEcCtD
Rosiglitazone—Cardiac failure—Prednisone—psoriatic arthritis	0.000792	0.00475	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.000786	0.00471	CcSEcCtD
Rosiglitazone—Weight increased—Triamcinolone—psoriatic arthritis	0.000769	0.00461	CcSEcCtD
Rosiglitazone—Weight increased—Methylprednisolone—psoriatic arthritis	0.000768	0.0046	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.000743	0.00446	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Methotrexate—psoriatic arthritis	0.000742	0.00445	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.000741	0.00445	CcSEcCtD
Rosiglitazone—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.000739	0.00443	CcSEcCtD
Rosiglitazone—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.000737	0.00442	CcSEcCtD
Rosiglitazone—Hepatic failure—Methotrexate—psoriatic arthritis	0.000719	0.00431	CcSEcCtD
Rosiglitazone—Weight increased—Betamethasone—psoriatic arthritis	0.000698	0.00419	CcSEcCtD
Rosiglitazone—Weight increased—Dexamethasone—psoriatic arthritis	0.000698	0.00419	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.000692	0.00415	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.000692	0.00415	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.000674	0.00404	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.000674	0.00404	CcSEcCtD
Rosiglitazone—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.00067	0.00402	CcSEcCtD
Rosiglitazone—Myocardial infarction—Betamethasone—psoriatic arthritis	0.00067	0.00402	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000663	0.00398	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.000659	0.00395	CcSEcCtD
Rosiglitazone—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000631	0.00378	CcSEcCtD
Rosiglitazone—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000626	0.00376	CcSEcCtD
Rosiglitazone—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00061	0.00366	CcSEcCtD
Rosiglitazone—Weight increased—Prednisone—psoriatic arthritis	0.000608	0.00365	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Prednisone—psoriatic arthritis	0.000602	0.00361	CcSEcCtD
Rosiglitazone—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000588	0.00352	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.000587	0.00352	CcSEcCtD
Rosiglitazone—Angioedema—Prednisolone—psoriatic arthritis	0.000585	0.00351	CcSEcCtD
Rosiglitazone—Myocardial infarction—Prednisone—psoriatic arthritis	0.000584	0.0035	CcSEcCtD
Rosiglitazone—Eye disorder—Dexamethasone—psoriatic arthritis	0.000574	0.00344	CcSEcCtD
Rosiglitazone—Eye disorder—Betamethasone—psoriatic arthritis	0.000574	0.00344	CcSEcCtD
Rosiglitazone—Back pain—Triamcinolone—psoriatic arthritis	0.00057	0.00342	CcSEcCtD
Rosiglitazone—Hypertension—Prednisolone—psoriatic arthritis	0.000553	0.00332	CcSEcCtD
Rosiglitazone—Angioedema—Triamcinolone—psoriatic arthritis	0.000538	0.00323	CcSEcCtD
Rosiglitazone—Angioedema—Methylprednisolone—psoriatic arthritis	0.000537	0.00322	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000525	0.00315	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000523	0.00313	CcSEcCtD
Rosiglitazone—Oedema—Prednisolone—psoriatic arthritis	0.000523	0.00313	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000519	0.00311	CcSEcCtD
Rosiglitazone—Hypertension—Triamcinolone—psoriatic arthritis	0.000508	0.00305	CcSEcCtD
Rosiglitazone—Hypertension—Methylprednisolone—psoriatic arthritis	0.000507	0.00304	CcSEcCtD
Rosiglitazone—Myalgia—Triamcinolone—psoriatic arthritis	0.000501	0.00301	CcSEcCtD
Rosiglitazone—Arthralgia—Methylprednisolone—psoriatic arthritis	0.0005	0.003	CcSEcCtD
Rosiglitazone—Myalgia—Methylprednisolone—psoriatic arthritis	0.0005	0.003	CcSEcCtD
Rosiglitazone—Eye disorder—Prednisone—psoriatic arthritis	0.0005	0.003	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000493	0.00296	CcSEcCtD
Rosiglitazone—Angioedema—Betamethasone—psoriatic arthritis	0.000488	0.00293	CcSEcCtD
Rosiglitazone—Angioedema—Dexamethasone—psoriatic arthritis	0.000488	0.00293	CcSEcCtD
Rosiglitazone—Immune system disorder—Prednisone—psoriatic arthritis	0.000483	0.0029	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000481	0.00288	CcSEcCtD
Rosiglitazone—Oedema—Triamcinolone—psoriatic arthritis	0.000481	0.00288	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00048	0.00288	CcSEcCtD
Rosiglitazone—Infection—Triamcinolone—psoriatic arthritis	0.000478	0.00286	CcSEcCtD
Rosiglitazone—Infection—Methylprednisolone—psoriatic arthritis	0.000476	0.00286	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000471	0.00282	CcSEcCtD
Rosiglitazone—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00047	0.00282	CcSEcCtD
Rosiglitazone—Malnutrition—Prednisone—psoriatic arthritis	0.000465	0.00279	CcSEcCtD
Rosiglitazone—Hypertension—Dexamethasone—psoriatic arthritis	0.000461	0.00277	CcSEcCtD
Rosiglitazone—Hypertension—Betamethasone—psoriatic arthritis	0.000461	0.00277	CcSEcCtD
Rosiglitazone—Myalgia—Dexamethasone—psoriatic arthritis	0.000455	0.00273	CcSEcCtD
Rosiglitazone—Myalgia—Betamethasone—psoriatic arthritis	0.000455	0.00273	CcSEcCtD
Rosiglitazone—Hepatitis—Methotrexate—psoriatic arthritis	0.000447	0.00268	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000438	0.00263	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000437	0.00262	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000436	0.00262	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000436	0.00262	CcSEcCtD
Rosiglitazone—Oedema—Dexamethasone—psoriatic arthritis	0.000436	0.00262	CcSEcCtD
Rosiglitazone—Oedema—Betamethasone—psoriatic arthritis	0.000436	0.00262	CcSEcCtD
Rosiglitazone—Infection—Betamethasone—psoriatic arthritis	0.000433	0.0026	CcSEcCtD
Rosiglitazone—Infection—Dexamethasone—psoriatic arthritis	0.000433	0.0026	CcSEcCtD
Rosiglitazone—Anaemia—Prednisone—psoriatic arthritis	0.00043	0.00258	CcSEcCtD
Rosiglitazone—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000428	0.00257	CcSEcCtD
Rosiglitazone—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000428	0.00257	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000427	0.00256	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000427	0.00256	CcSEcCtD
Rosiglitazone—Angioedema—Prednisone—psoriatic arthritis	0.000425	0.00255	CcSEcCtD
Rosiglitazone—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000422	0.00253	CcSEcCtD
Rosiglitazone—Eye disorder—Methotrexate—psoriatic arthritis	0.000418	0.0025	CcSEcCtD
Rosiglitazone—Urticaria—Prednisolone—psoriatic arthritis	0.000415	0.00249	CcSEcCtD
Rosiglitazone—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000415	0.00249	CcSEcCtD
Rosiglitazone—Fatigue—Triamcinolone—psoriatic arthritis	0.000414	0.00249	CcSEcCtD
Rosiglitazone—Fatigue—Methylprednisolone—psoriatic arthritis	0.000413	0.00248	CcSEcCtD
Rosiglitazone—Immune system disorder—Methotrexate—psoriatic arthritis	0.000404	0.00242	CcSEcCtD
Rosiglitazone—Hypertension—Prednisone—psoriatic arthritis	0.000402	0.00241	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000397	0.00238	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000397	0.00238	CcSEcCtD
Rosiglitazone—Myalgia—Prednisone—psoriatic arthritis	0.000396	0.00238	CcSEcCtD
Rosiglitazone—Arthralgia—Prednisone—psoriatic arthritis	0.000396	0.00238	CcSEcCtD
Rosiglitazone—Malnutrition—Methotrexate—psoriatic arthritis	0.000389	0.00233	CcSEcCtD
Rosiglitazone—Urticaria—Triamcinolone—psoriatic arthritis	0.000382	0.00229	CcSEcCtD
Rosiglitazone—Urticaria—Methylprednisolone—psoriatic arthritis	0.000381	0.00229	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00038	0.00228	CcSEcCtD
Rosiglitazone—Oedema—Prednisone—psoriatic arthritis	0.00038	0.00228	CcSEcCtD
Rosiglitazone—Infection—Prednisone—psoriatic arthritis	0.000377	0.00226	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000377	0.00226	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000377	0.00226	CcSEcCtD
Rosiglitazone—Back pain—Methotrexate—psoriatic arthritis	0.000376	0.00226	CcSEcCtD
Rosiglitazone—Fatigue—Dexamethasone—psoriatic arthritis	0.000376	0.00226	CcSEcCtD
Rosiglitazone—Fatigue—Betamethasone—psoriatic arthritis	0.000376	0.00226	CcSEcCtD
Rosiglitazone—Nervous system disorder—Prednisone—psoriatic arthritis	0.000372	0.00223	CcSEcCtD
Rosiglitazone—Anaemia—Methotrexate—psoriatic arthritis	0.000359	0.00216	CcSEcCtD
Rosiglitazone—Leukopenia—Methotrexate—psoriatic arthritis	0.000348	0.00209	CcSEcCtD
Rosiglitazone—Urticaria—Dexamethasone—psoriatic arthritis	0.000346	0.00208	CcSEcCtD
Rosiglitazone—Urticaria—Betamethasone—psoriatic arthritis	0.000346	0.00208	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000346	0.00208	CcSEcCtD
Rosiglitazone—Dizziness—Prednisolone—psoriatic arthritis	0.000346	0.00207	CcSEcCtD
Rosiglitazone—Asthenia—Triamcinolone—psoriatic arthritis	0.000345	0.00207	CcSEcCtD
Rosiglitazone—Asthenia—Methylprednisolone—psoriatic arthritis	0.000344	0.00206	CcSEcCtD
Rosiglitazone—Pruritus—Triamcinolone—psoriatic arthritis	0.00034	0.00204	CcSEcCtD
Rosiglitazone—Pruritus—Methylprednisolone—psoriatic arthritis	0.000339	0.00204	CcSEcCtD
Rosiglitazone—Arthralgia—Methotrexate—psoriatic arthritis	0.000331	0.00199	CcSEcCtD
Rosiglitazone—Myalgia—Methotrexate—psoriatic arthritis	0.000331	0.00199	CcSEcCtD
Rosiglitazone—Rash—Prednisolone—psoriatic arthritis	0.00033	0.00198	CcSEcCtD
Rosiglitazone—Dermatitis—Prednisolone—psoriatic arthritis	0.000329	0.00197	CcSEcCtD
Rosiglitazone—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000328	0.00197	CcSEcCtD
Rosiglitazone—Fatigue—Prednisone—psoriatic arthritis	0.000327	0.00196	CcSEcCtD
Rosiglitazone—Headache—Prednisolone—psoriatic arthritis	0.000327	0.00196	CcSEcCtD
Rosiglitazone—Constipation—Prednisone—psoriatic arthritis	0.000325	0.00195	CcSEcCtD
Rosiglitazone—Dizziness—Triamcinolone—psoriatic arthritis	0.000318	0.00191	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000317	0.0019	CcSEcCtD
Rosiglitazone—Dizziness—Methylprednisolone—psoriatic arthritis	0.000317	0.0019	CcSEcCtD
Rosiglitazone—Infection—Methotrexate—psoriatic arthritis	0.000315	0.00189	CcSEcCtD
Rosiglitazone—Asthenia—Betamethasone—psoriatic arthritis	0.000313	0.00188	CcSEcCtD
Rosiglitazone—Asthenia—Dexamethasone—psoriatic arthritis	0.000313	0.00188	CcSEcCtD
Rosiglitazone—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000311	0.00187	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000311	0.00186	CcSEcCtD
Rosiglitazone—Nausea—Prednisolone—psoriatic arthritis	0.00031	0.00186	CcSEcCtD
Rosiglitazone—Pruritus—Dexamethasone—psoriatic arthritis	0.000309	0.00185	CcSEcCtD
Rosiglitazone—Pruritus—Betamethasone—psoriatic arthritis	0.000309	0.00185	CcSEcCtD
Rosiglitazone—Rash—Triamcinolone—psoriatic arthritis	0.000303	0.00182	CcSEcCtD
Rosiglitazone—Dermatitis—Triamcinolone—psoriatic arthritis	0.000303	0.00182	CcSEcCtD
Rosiglitazone—Rash—Methylprednisolone—psoriatic arthritis	0.000302	0.00181	CcSEcCtD
Rosiglitazone—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000302	0.00181	CcSEcCtD
Rosiglitazone—Urticaria—Prednisone—psoriatic arthritis	0.000302	0.00181	CcSEcCtD
Rosiglitazone—Headache—Triamcinolone—psoriatic arthritis	0.000301	0.00181	CcSEcCtD
Rosiglitazone—Headache—Methylprednisolone—psoriatic arthritis	0.0003	0.0018	CcSEcCtD
Rosiglitazone—Diarrhoea—Betamethasone—psoriatic arthritis	0.000298	0.00179	CcSEcCtD
Rosiglitazone—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000298	0.00179	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000289	0.00173	CcSEcCtD
Rosiglitazone—Dizziness—Betamethasone—psoriatic arthritis	0.000288	0.00173	CcSEcCtD
Rosiglitazone—Dizziness—Dexamethasone—psoriatic arthritis	0.000288	0.00173	CcSEcCtD
Rosiglitazone—Nausea—Triamcinolone—psoriatic arthritis	0.000286	0.00171	CcSEcCtD
Rosiglitazone—Nausea—Methylprednisolone—psoriatic arthritis	0.000285	0.00171	CcSEcCtD
Rosiglitazone—Rash—Betamethasone—psoriatic arthritis	0.000275	0.00165	CcSEcCtD
Rosiglitazone—Rash—Dexamethasone—psoriatic arthritis	0.000275	0.00165	CcSEcCtD
Rosiglitazone—Dermatitis—Betamethasone—psoriatic arthritis	0.000275	0.00165	CcSEcCtD
Rosiglitazone—Dermatitis—Dexamethasone—psoriatic arthritis	0.000275	0.00165	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000274	0.00164	CcSEcCtD
Rosiglitazone—Fatigue—Methotrexate—psoriatic arthritis	0.000274	0.00164	CcSEcCtD
Rosiglitazone—Headache—Betamethasone—psoriatic arthritis	0.000273	0.00164	CcSEcCtD
Rosiglitazone—Headache—Dexamethasone—psoriatic arthritis	0.000273	0.00164	CcSEcCtD
Rosiglitazone—Asthenia—Prednisone—psoriatic arthritis	0.000273	0.00163	CcSEcCtD
Rosiglitazone—Pruritus—Prednisone—psoriatic arthritis	0.000269	0.00161	CcSEcCtD
Rosiglitazone—Diarrhoea—Prednisone—psoriatic arthritis	0.00026	0.00156	CcSEcCtD
Rosiglitazone—Nausea—Dexamethasone—psoriatic arthritis	0.000259	0.00155	CcSEcCtD
Rosiglitazone—Nausea—Betamethasone—psoriatic arthritis	0.000259	0.00155	CcSEcCtD
Rosiglitazone—Urticaria—Methotrexate—psoriatic arthritis	0.000252	0.00151	CcSEcCtD
Rosiglitazone—Dizziness—Prednisone—psoriatic arthritis	0.000251	0.00151	CcSEcCtD
Rosiglitazone—Rash—Prednisone—psoriatic arthritis	0.000239	0.00144	CcSEcCtD
Rosiglitazone—Dermatitis—Prednisone—psoriatic arthritis	0.000239	0.00144	CcSEcCtD
Rosiglitazone—Headache—Prednisone—psoriatic arthritis	0.000238	0.00143	CcSEcCtD
Rosiglitazone—Asthenia—Methotrexate—psoriatic arthritis	0.000228	0.00137	CcSEcCtD
Rosiglitazone—Nausea—Prednisone—psoriatic arthritis	0.000226	0.00135	CcSEcCtD
Rosiglitazone—Pruritus—Methotrexate—psoriatic arthritis	0.000225	0.00135	CcSEcCtD
Rosiglitazone—Diarrhoea—Methotrexate—psoriatic arthritis	0.000217	0.0013	CcSEcCtD
Rosiglitazone—Dizziness—Methotrexate—psoriatic arthritis	0.00021	0.00126	CcSEcCtD
Rosiglitazone—Rash—Methotrexate—psoriatic arthritis	0.0002	0.0012	CcSEcCtD
Rosiglitazone—Dermatitis—Methotrexate—psoriatic arthritis	0.0002	0.0012	CcSEcCtD
Rosiglitazone—Headache—Methotrexate—psoriatic arthritis	0.000199	0.00119	CcSEcCtD
Rosiglitazone—Nausea—Methotrexate—psoriatic arthritis	0.000189	0.00113	CcSEcCtD
